POLQ- and CtIP-regulated telomere fusions and translocations are involved in early events in carcinogenesis
POLQ- and CtIP-regulated telomere fusions and translocations are involved in early events in carcinogenesis
批准号:
10673149
负责人:
ERIC A HENDRICKSON
金额:
$49.95万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-08-01 至 2027-07-31
关键词:
AddressAgingAneuploidyApplications GrantsAreaAwardBeliefBiologyBone marrow failureBypassC-terminalCancer BiologyCell DeathCell LineCell SurvivalCellsChromosomesCollaborationsComplementDNADNA Double Strand BreakDNA RepairDNA ligase IIIDNA-Directed DNA PolymeraseDataDiseaseDyskeratosis CongenitaEnsureEventExcisionFrequenciesGene MutationGene TargetingGenesGeneticGenomeGenomic InstabilityGoalsHumanInvestigationKnowledgeLaboratoriesLigaseMaintenanceMalignant NeoplasmsMediatingMedicineModelingMusMutationNobel PrizeNonhomologous DNA End JoiningNull LymphocytesOutcomePathologicPathway interactionsPhysiologyPlayPoly(ADP-ribose) PolymerasesPolymeraseProcessProductionProliferatingProteinsPublicationsRegulationResolutionRoleSister ChromatidStructureSyndromeSystemTechnologyTelomeraseTelomere MaintenanceTelomere ShorteningUltrafinecancer predispositioncarcinogenesiscell agecell transformationchromosome fusionchromothripsisexperimental studyloss of functionloss of function mutationmutantnovelnucleasepreventprogenitorrepairedresponsesenescencesingle moleculetelomeretumorigenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
We propose to investigate the mechanisms that regulate a cell’s ability to escape from the crisis caused by
telomere shortening. As normal human cells age, their telomeres gradually shorten. When the telomeres
shorten significantly, the cell undergoes senescence, which is a naturally occurring barrier to cancer. If,
however, a cell should suffer a transforming mutation, it can by-pass senescence and continue to proliferate
until its telomeres become so short that they are non-functional. The resulting lack of end protection triggers
“crisis”, a state that is highlighted by genomic instability as chromosomes engage in breakage:fusion:bridging
cycles that almost invariably result in the death of the cell. On rare occasions a cell can resolve its fusions,
reestablish its telomeres and stabilize its genome. Such cells are said to be immortalized and it is likely that
they are the progenitors of most human cancers. That the (dys)regulation of telomere maintenance is also
associated with aging, immortalization, and tumorigenesis in other experimental systems adds confidence to
the belief that these issues are conserved and important. Previously, we have demonstrated that DNA ligase III
and poly (ADP) ribose polymerase 1 are required for human cells to survive crisis. Here, we propose to define
the role of DNA polymerase theta/Q (POLQ), which acts in the same pathway, in this process. Unexpectedly,
we show that deletion of POLQ causes telomere elongation and escape from crisis. We will uncover how
POLQ normally suppresses these events.
Integral to surviving crisis is a requirement to resolve the chromosomal fusions/translocations that occurred
during crisis. One way to do this is to physically shear them apart by the application of tension (aka,
“breakage”). This process, however, is highly mutagenic and often leads to lethal outcomes. A second
resolution process more likely to ensure survival is to convert the chromosome fusions into ultra-fine bridges
(UFBs) and then enzymatically — in a process that is very poorly understood — resolve these UFBs. Here, we
demonstrate that the loss-of-function of the resection nuclease, C-terminal interacting protein (CtIP), results in
a high frequency of UFBs that are not resolved and we propose experiments to mechanistically unravel how
these bridges, many of which involve telomeres, are generated and why they are not resolved. In all of these
approaches we utilize the strengths of the Hendrickson and Baird laboratories. The Hendrickson laboratory
excels at the technology of gene targeting to study the impact of loss-of-function mutations of genes (POLQ
and CtIP in this instance) on telomere maintenance. The Baird laboratory is the world’s leader in analyzing
telomere fusion events in human cells undergoing crisis. Their ability to characterize the dynamics of single
telomeric ends has provided the field’s deepest understanding of the mechanism of telomere fusions in human
cells. In summary, our proposed studies impact on DNA repair and telomere maintenance and the importance
of understanding these processes for cancer biology is clear.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1371/journal.pgen.1010485
发表时间:
2022-11
期刊:
PLoS genetics
影响因子:
4.5
作者:
[]
通讯作者:
DOI:
10.1093/narcan/zcac020
发表时间:
2022-09
期刊:
NAR cancer
影响因子:
5.1
作者:
[]
通讯作者:
POLQ- and CtIP-regulated telomere fusions and translocations are involved in early events in carcinogenesis
-
批准号:10770273
-
项目类别:
-
资助金额:$29.45万
-
财政年份:2022
-
负责人:ERIC A HENDRICKSON
-
依托单位:
Ligase III regulates survival from crisis induced by gradual telomere shortening
-
批准号:9114537
-
项目类别:
-
资助金额:$33.52万
-
财政年份:2015
-
负责人:ERIC A HENDRICKSON
-
依托单位:
Ligase III regulates survival from crisis induced by gradual telomere shortening
-
批准号:9308903
-
项目类别:
-
资助金额:$33.52万
-
财政年份:2015
-
负责人:ERIC A HENDRICKSON
-
依托单位:
Ku regulates non-homologous end joining pathways in human somatic cells
-
批准号:8298501
-
项目类别:
-
资助金额:$30.73万
-
财政年份:2011
-
负责人:ERIC A HENDRICKSON
-
依托单位:
Ku regulates non-homologous end joining pathways in human somatic cells
-
批准号:8527889
-
项目类别:
-
资助金额:$1.55万
-
财政年份:2011
-
负责人:ERIC A HENDRICKSON
-
依托单位:
Ku regulates non-homologous end joining pathways in human somatic cells
-
批准号:8658400
-
项目类别:
-
资助金额:$29.77万
-
财政年份:2011
-
负责人:ERIC A HENDRICKSON
-
依托单位:
Ku regulates non-homologous end joining pathways in human somatic cells
-
批准号:8820471
-
项目类别:
-
资助金额:$1.89万
-
财政年份:2011
-
负责人:ERIC A HENDRICKSON
-
依托单位:
Ku regulates non-homologous end joining pathways in human somatic cells
-
批准号:8193446
-
项目类别:
-
资助金额:$29.98万
-
财政年份:2011
-
负责人:ERIC A HENDRICKSON
-
依托单位:
Ku regulates non-homologous end joining pathways in human somatic cells
-
批准号:8460914
-
项目类别:
-
资助金额:$28.87万
-
财政年份:2011
-
负责人:ERIC A HENDRICKSON
-
依托单位:
Ku regulates non-homologous end joining pathways in human somatic cells
-
批准号:8649877
-
项目类别:
-
资助金额:$1.83万
-
财政年份:2011
-
负责人:ERIC A HENDRICKSON
-
依托单位:
DNA Double-Strand Break Repair Regulates rAAV-Mediated Gene Targeting
-
批准号:8434196
-
项目类别:
-
资助金额:$27.38万
-
财政年份:2010
-
负责人:ERIC A HENDRICKSON
-
依托单位:
DNA Double-Strand Break Repair Regulates rAAV-Mediated Gene Targeting
-
批准号:7779935
-
项目类别:
-
资助金额:$28.66万
-
财政年份:2010
-
负责人:ERIC A HENDRICKSON
-
依托单位:
DNA Double-Strand Break Repair Regulates rAAV-Mediated Gene Targeting
-
批准号:8233524
-
项目类别:
-
资助金额:$28.37万
-
财政年份:2010
-
负责人:ERIC A HENDRICKSON
-
依托单位:
DNA Double-Strand Break Repair Regulates rAAV-Mediated Gene Targeting
-
批准号:8045508
-
项目类别:
-
资助金额:$28.37万
-
财政年份:2010
-
负责人:ERIC A HENDRICKSON
-
依托单位:
Novel Human Cell Lines for the Study of Primary Immunodeficiencies
-
批准号:8067817
-
项目类别:
-
资助金额:$18.4万
-
财政年份:2010
-
负责人:ERIC A HENDRICKSON
-
依托单位:
Novel Human Cell Lines for the Study of Primary Immunodeficiencies
-
批准号:7771176
-
项目类别:
-
资助金额:$22.36万
-
财政年份:2010
-
负责人:ERIC A HENDRICKSON
-
依托单位:
Ku86 Controls DNA Repair, Telomeres & Genomic Stability
-
批准号:7212192
-
项目类别:
-
资助金额:$23.93万
-
财政年份:2005
-
负责人:ERIC A HENDRICKSON
-
依托单位:
Ku86 Controls DNA Repair, Telomeres & Genomic Stability
-
批准号:7391189
-
项目类别:
-
资助金额:$23.9万
-
财政年份:2005
-
负责人:ERIC A HENDRICKSON
-
依托单位:
Ku86 Controls DNA Repair, Telomeres & Genomic Stability
-
批准号:6921119
-
项目类别:
-
资助金额:$25.08万
-
财政年份:2005
-
负责人:ERIC A HENDRICKSON
-
依托单位:
Ku86 Controls DNA Repair, Telomeres & Genomic Stability
-
批准号:7026451
-
项目类别:
-
资助金额:$24.67万
-
财政年份:2005
-
负责人:ERIC A HENDRICKSON
-
依托单位:
海外基金